Aurobindo Pharma524804Acquisition deal news
Aurobindo arm A1 Biocheme USA Inc completes 100% acquisition of A1 Biocheme Labs LLC for USD 15.247 Mn
100%Ownership acquired in A1 Biocheme Labs LLC
- Consideration
- Cash consideration of USD 15.247 Mn
- Stake Acquired
- 100% ownership / 100% membership interest in A1 Biocheme Labs LLC
- Target
- A1 Biocheme Labs LLC, Wilmington, North Carolina, USA
- Acquirer
- A1 Biocheme USA Inc, a step-down subsidiary
- Objective
- create a dedicated CRDMO platform, expand presence in the API life cycle
Aurobindo arm A1 Biocheme USA Inc completes 100% acquisition of A1 Biocheme Labs LLC for USD 15.247 Mn.
Turnover period end
Turnover period end
Acquisition completed subject to customary conditions under the Definitive Agreements
Also from Aurobindo Pharma
USFDA final approval received for Perampanel Tablets in 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg
3 Oct 2026
Subsidiary completes acquisition of A1 Biochem Group's contract research business
2 Oct 2026
Aurobindo's step-down arm A1 Biochem Labs allots shares and CCDs worth INR 33.80 crore, Apitoria stake down to 80%
1 Oct 2026
More numbers
- Cash considerationUSD 15.247 Mn
- Ownership acquired in A1 Biocheme Labs LLC100%
- Turnover for calendar year ended 31 December 2023USD 6.35 Million
- Turnover for calendar year ended 31 December 2024USD 9.23 Million
- Turnover for calendar year ended 31 December 2025USD 5.92 Million
Source: BSE · 2 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.